Abstract. Autogenous microfat grafting is widely used to augment depressed deformities or for other cosmetic purposes. Since the microfat survival rate is unpredictable due to absorption and calcification, previously cryopreserved fat is widely used for secondary procedures. Sphingosylphosphorylcholine (SPC) is a lysophospholipid, which has a role in several cellular responses, and is known to stimulate DNA synthesis and proliferation. Since endothelial progenitor cells (EPCs) are known to enhance the survival rate of transplanted fat tissue, the present study assessed the effects of SPC on EPCs, in order to verify its positive effects on proliferation. Cryopreserved human fat tissues mixed with various concentrations of SPC were grafted into the nude mouse model. After grafting, the viability of each SPC mixed group was determined and compared with that of the non-SPC group. SPC exhibited a positive effect on EPC proliferation and angiogenic potential over 3 days when used at specific concentrations. The fat grafts of the 3 µM SPC-treated group weighed significantly more and the volume was markedly increased, as compared with the control group. A reverse transcription-quantitative polymerase chain reaction was conducted on the total RNA extracted from SPC-treated fat tissues, which detected increased mRNA expression levels of matrix metallopeptidase-9 and tumor necrosis factor-α compared with in the control group. These results indicate that specific concentrations of SPC may exert favorable effects on grafted cryopreserved human fat tissue, which may be due to the increased mRNA expression levels of genes associated with angiogenesis.
Introduction
Autogenous microfat grafting is a popular and relatively simple procedure, which is widely used to augment depressed deformities or for other cosmetic purposes. Various temporary and permanent fillers have been used as alternatives with varying degrees of success (1); however, the autogenous microfat grafting technique is most commonly selected by surgeons because it is easy to perform, produces no ill-effects associated with foreign body reactions, and can compensate for large volume deficits.
Despite numerous advantages associated with the use of microfat grafting for soft tissue recontouring, some problems must be considered with regards to this procedure, particularly with regards to the unpredictability of the final survival rate due to absorption and calcification. In addition, microfat retouching must be frequently performed a few months after the initial procedure using previously cryopreserved fat tissues. However, cryopreserved fat tissues tend to exhibit greater absorption with re-grafting compared with the initial procedure, and increased survival of the cryopreserved fat tissues is indispensable to the final result. To prevent unintended absorption, grafted fat tissues should be revascularized within a short time period (2) .
Sphingosylphosphorylcholine (SPC) is a lysophospholipid with a role in several cellular responses, including migration, wound healing and differentiation, which is known to stimulate DNA synthesis and proliferation (3) . A strong mitogenic effect of SPC has also been observed in numerous types of cells, including endothelial cells from different vascular beds (4) .
It has previously been demonstrated that endothelial progenitor cells (EPCs) can become incorporated into active sites of angiogenesis, and augment collateral vessel growth to ischemic tissues (5) . In a previous study, EPCs were reported to enhance the survival rate of transplanted fat tissues, possibly due to the induction of angiogenesis (6) . However, the use of EPCs in the fat graft domain is limited because it requires human donors and an in vitro culture period of >7 days. Therefore, the present study aimed to determine the effects of SPC on EPCs in vitro, in order to confirm the usefulness of employing SPC in cryopreserved fat tissues to improve post-transplantation fat graft survival rates. To verify the effects of SPC on fat tissues in vivo, cryopreserved human fat tissues were mixed with various concentrations of SPC and the effects were analyzed. Cell culture. The EPCs were obtained from the Korean Cell Line Bank (Seoul, South Korea) and were maintained at 37˚C in an atmosphere containing 5% CO 2 , in EBM-2 (CC-3162; Lonza Group AG) supplemented with EGM-2 Bullet kit (CC3156 and CC-4176; Lonza Group AG) and 5% FBS. There cells were then sub-cultured to 90% confluencey for 3-5 days using 0.05% trypsin EDTA. In the experiments of the present study, the cells used were sub-cultured less than eight times.
Effects of sphingosylphosphorylcholine on cryopreserved fat tissue graft survival
MTT proliferation assay. EPC proliferation was evaluated using an MTT assay. The cells were plated at a density of 1x10 4 cells/well in 24-well plates, were serum-starved for 24 h, and were then treated with or without various reagents [SPC (0.1, 0.5, 1, 3, 5, 10 and 15 µM), PTX (1, 5, 10, 50 and 100 nM) or VPC23019 (1, 2, 3, 5, 7 and 10 µM)] for the indicated durations (1, 2, 3 and 4 days). After washing, culture medium containing 0.5 mg/ml MTT was added to each well. The cells were then incubated for 2 h at 37˚C, after which the supernatant was removed and the formazan crystals that had formed in the viable cells were solubilized using 200 µl DMSO. A 100 µl aliquot of each sample was then transferred to a well in a 96-well plate, and the absorbance was measured at 560 nm using a microplate reader and XFLUOR4 software version 4.51 (Tecan Group, Männedorf, Swizerland). This experiment was repeated four times.
In vitro EPC tube formation. The in vitro angiogenic potential of SPC was assessed by the ability of the EPCs to form tubes on a basement membrane matrix (BD Matrigel™ Matrix; BD Biosciences, Franklin Lakes, NJ, USA). The EPCs were plated at a density of 1x10 2 cells/well in a 96-well plate and were treated with 1, 3, 5, 10 and 15 µM SPC. The EPCs were evaluated using a light microscope (Olympus, Tokyo, Japan) under x200 magnification after 12 h of culture (7).
Human fat tissue. Adipose tissue was obtained from an elective surgery. The patient provided written informed consent, and the study was approved by the Institutional Review Board of Pusan National University Hospital (Busan, South Korea). Adipose tissue was obtained through suction-assisted lipectomy from a 22-year-old healthy woman undergoing suction-assisted lipectomy under general anesthesia. The areas were injected with a local anesthetic solution containing lidocaine (0.05%) and adrenaline (1:1,000,000) prior to the start of the procedure. The fat was aspirated using a sterile 10 ml syringe and a 14-gauge cannula with a blunt tip. The aspirated fat was processed under sterile conditions by two-step centrifugation (4 min each; 1,200 x g). The aspirated fat tissue was frozen at -20˚C for 8 weeks until being used in the transplantation experiments. Prior to transplantation, the fat was thawed for 1 h in a 37˚C water bath.
Animal model and fat transplantation. The animal experiment used 48 male Balb/C nude mice (Biogenomics, Inc., Seoul, Korea; age, 6 weeks; weight, 20-30 g). During the study, mice were housed under constant laminar airflow and were fed standard laboratory chow and water. They were kept under an artificial 12 h light/dark cycle at a constant temperature range (24±2˚C) and relative humidity (55±10%). Nude mice have previously been used to study fat grafts and enable the observation of the use of human fat in an animal model (8, 9) . The mice were divided into 1, 3, 5, 10 and 15 µM SPC-treated groups, and the control group (n=8 mice/group). Mice in the SPC-treated groups received a combination of 0.4 ml cryopreserved fat and 0.02 ml SPC (1, 3, 5, 10 or 15 µM). Mice in the control group received a combination of 0.4 ml fat and 0.02 ml normal saline. Fat was injected subcutaneously into the back of each mouse using a 16-G sharp needle (Coleman injection cannula; Mentor Worldwide LLC, Santa Barbara, CA, USA). The Animal Care and Experiment Committee of Pusan National University (Busan, South Korea) approved the experimental protocol.
Follow-up and data collection. The mice were humanely sacrificed by CO 2 asphyxiation 8 weeks after fat transplantation. The grafted fat was carefully dissected from their backs, and its volume and weight were measured. The volume was determined using the liquid overflow method (10) . Fat samples from the six mouse groups [untreated control group, and SPC-treated groups (1, 3, 5 , 10 and 15 µM)] were fixed in 10% formalin and embedded in paraffin. Tissue sections were acquired from the center of the dissected fat biopsy. For CD31 staining, 5-mm sections were permeabilized with 0.3% Triton X-100 for 10 min, then blocked for 1 h with 8% bovine serum albumin (BSA) at room temperature. Primary rabbit anti-CD31 antibodies (cat. no. Ab28364, Abcam Cambridge, MA, USA) were diluted to 1:500 in phosphate-buffered saline (PBS) with 2% BSA, and were incubated with the sections overnight at 4˚C. The biotinylated goat anti-rabbit immunoglobulin G (cat. no. BA-1000, Vector Laboratories: Burlingame, CA, USA) were diluted to 1:100 in PBS and incubated for 1 h at room temperature. Staining was visualized using biotin-avidin-peroxidase complexes (Vector Laboratories) and diaminobenzidine (Vector Laboratories). Images were collected using a Leica TCL-SP2 confocal microscope system at x200 magnification (Leica Microsystems Heidelberg GmbH, Heidelberg, Germany).
Reverse transcription-quantitative polymerase chain reaction (RT-qPCR).
Total cellular RNA was isolated from the EPCs or homogenized fat using TRIzol ® reagent (Invitrogen; Thermo Fisher Scientific, Waltham, MA, USA). The total RNA (2 µg) was then reverse transcribed into cDNA with the Reverse Transcriptase M-MLV (Promega Corporation, Madison, WI, USA) according to the manufacturer's protocol. The primers used in the experiment were as follows: β-actin, forward 5'-CTG GTG CCT GGG GCG-3', reverse 5'-AGC CTC GCC TTT GCC GA-3'; human growth factor (HGF), forward 5'-CCT ATG CAG AGG GAC AAA GG-3', reverse 5'-TGC TAT TGA AGG GGA ACC AG-3'; interleukin-6 (IL-6), forward 5'-AAA GAG GCA CTG GCA GAA AA-3' , reverse 5'-CAG GGG TGG TTA TTG CATCT3 '; tumor necrosis factor-α (TNF-α), forward 5'-GAC AAG CCT GTA GCC CAT GT-3' , reverse 5'TTG ATG GCA GAG AGG AGGTT-3'; matrix metallopeptidase (MMP)-2, forward 5'-CAG GTG ATC TTG ACC AGA AT-3, reverse 5'-CAT CAT GGA TTC GAG AAA AC-3'; MMP-9, forward 5'-ACC TCG AAC TTT GAC AGC GAC A-3', reverse 5'-GAT GCC ATT CAC GTC GTC CTT A-3'; and vascular endothelial growth factor (VEGF), forward 5'-AAG GAG GAG GGC AGA ATC AT-3', and reverse 5'-ATC TGC ATG GTG ATG TTG GA-3' (Bioneer Corporation, Deajeon, Korea). All of the primer sequences were determined according to established GenBank sequences (http://www.ncbi.nlm.nih. gov/genbank/). RT-qPCR was conducted using a Power SYBR Green PCR Master mix (Applied Biosystems, Warrington, UK) on the ABI 7500 Instrument (Applied Biosystems). The reaction mixture contained 2 µl of 10 ng/µl cDNA, 10 µl SYBR (qPCR master mix), 0.5 µl of 10 pmol forward primer, 0.5 µl of 10 pmol reverse primer and 7 µl nuclease-free water to produce a final volume of 20 µl. The amplification program consisted of one cycle at 95˚C with a 60 sec hold (ʻhot startʼ) followed by 40 cycles at 95˚C with a 0 sec hold, a 60˚C annealing step with a 5 sec hold, 72˚C with a 12 sec hold, and a 60˚C acquisition step with a 2 sec hold. All experiments were conducted three times, and negative and positive controls were included in all experiments. β-actin mRNA was amplified as an internal control. LightCycler software version 3.3 (Roche Diagnostics) was used to analyze the PCR kinetics and calculate the quantitative data. For each sample, copy numbers of target gene mRNA were divided by those of β-actin mRNA to normalize for target gene mRNA expression and avoid inter-sample differences in RNA quantity.
Statistical analysis.
The results are presented as the mean ± standard error of the mean. Comparisons between groups were analyzed using the Student's t-test or one-way analysis of variance for multiple groups. Tukey's adjustment post-hoc test was conducted to determine which means were significantly different. The statistical analysis of differences in fat graft weight and volume among the six groups was performed using Mann Whitney U-test. SPSS for Windows (version 17.0; SPSS, Inc., Chicago, IL, USA) was used to analyze the data. P<0.05 was considered to indicate a statistically significant difference.
Results
Effects of SPC on EPC proliferation. SPC exhibited a maximal effect on EPC proliferation when used at 3 (P=0.0013) and 5 µM (P=0.0005; Fig. 1A) . The positive effects of SPC were still efficacious at day 3 (Fig. 1B) . Conversely, PTX exhibited a direct dose-dependent cytotoxic effect on EPCs (Fig. 1C) , whereas VPC23019 had no effect on proliferation (Fig. 1D) . To confirm the positive effects of SPC on EPC growth, cells were co-treated with SPC and VPC23019. EPC growth was promoted by treatment with SPC, which was suppressed following the addition of VPC23019 (Fig. 1E) .
Effects of SPC on EPC angiogenesis. In vitro tube formation was increased following treatment of EPCs with SPC in a dose-dependent manner ( Fig. 2A) . RT-qPCR was conducted on total RNA extracted from EPCs treated with various concentrations of SPC, which detected increased mRNA expression levels of HGF, IL-6, MMP-2, MMP-9, TNF-α and VEGF, (Fig. 2B) .
Effects of SPC on cryopreserved fat tissue survival. Grafted fat was retrieved from the mice and the gross findings exhibited a significant bulk increase in the 3 µM SPC-treated group (Fig. 3) . Weight and volume measurements indicated that grafted fat survival was increased when treated with various concentrations of SPC. Statistical analysis was performed and the 3 µM SPC-treated group exhibited a statistically significant increase (P=0.04) in both weight and volume (Table I) .
Effects of SPC on cryopreserved fat tissue angiogenesis.
Increased angiogenesis of the SPC-treated fat graft tissue of the grafted fat tissue was detected by immunohistochemistry, as evidenced by increased CD31 expression (Fig. 4A) .
RT-qPCR analysis of total RNA extracted from SPC-treated fat tissue revealed increased mRNA expression levels of MMP9 (P=0.0001) and TNF-α (P=0.0024) compared with the control group (Fig. 4B ).
Discussion
SPC is reportedly associated with various cellular functions of the cardiovascular system, skin, neurons, and immune cells (3, 4, 9, 11) ; however, its effects on the survival of grafted fat tissues have yet to be reported. The present study demonstrated that SPC exerted strong mitogenic effects on endothelial cells, and an in vitro study was conducted to elucidate the direct mitogenic effect of A B SPC on EPCs. EPC proliferation was increased following SPC treatment, and proliferation peaked when the cells were treated with 3 or 5 µM SPC; this effect lasted for 3 days. Co-treatment with VPC23019, an inhibitor of the downstream SPC mediator sphingosine-1-phosphate, confirmed that significant EPC proliferation resulted from SPC treatment. In addition, tube formation assay and RT-qPCR demonstrated that SPC was able to increase the angiogenic potential of EPCs. An in vivo experiment using cryopreserved human fat tissue to conduct a fat graft in mice demonstrated statistically significant differences in weight and volume between the control and 3 µM SPC-treated groups.
With the favorable histological outcome, immunohistochemical result, and RT-qPCR findings of the present study, SPC may increase the survival rate of cryopreserved fat tissue by improving its angiogenic potential.
Previous studies have reported that SPC can stimulate the proliferation of human adipose tissue-derived mesenchymal stem cells (hADSC) (12, 13) . Therefore, the increased survival of cryopreserved fat detected in the present study may also be caused by SPC-induced hADSC proliferation. These results suggested that with an SPC-induced intensified EPC role in transplanted fat tissue, the cryopreserved fat survival rate could be further increased. In addition, these results indicated that specific concentrations of SPC have a favorable role in grafted cryopreserved human fat tissue, and this positive effect may be promoted by increased angiogenesis-associated mRNA expression. A B
